Twelve to fourteen weeks of use
For someone who has been consistent with semaglutide but has hit a plateau or hasnt achieved their desired weight loss goals, transitioning to tirzepatide could offer a new pathway to progress
Di recente, la ricerca ha dimostrato che i farmaci GLP-1 producono ulteriori benefici per la salute oltre al controllo del glucosio e del peso, tra cui la riduzione delle malattie cardiache e renali
1, Table 1, Extended Data Tables 1 and 2, and Supplementary Section 4) and substance-use disorders (via modulation of dopaminergic pathways of reward, impulse control and decision-making
Your provider may discuss which format aligns with your adherence preferences, insurance approval timeline, and clinical goals